Jason D. Brubaker

Person

Cambridge, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Wild type kit inhibitors
- Patent number 12,269,824
- Issue date Apr 8, 2025
- Blueprint Medicines Corporation
- Jason D. Brubaker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MAP4K1 inhibitors
- Patent number 12,202,844
- Issue date Jan 21, 2025
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EGFR inhibitors
- Patent number 12,172,983
- Issue date Dec 24, 2024
- Blueprint Medicines Corporation
- John Emmerson Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
MAP4K1 inhibitors
- Patent number 12,042,495
- Issue date Jul 23, 2024
- Blueprint Medicines Corporation
- Jason D. Brubaker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
EGFR inhibitors
- Patent number 11,718,602
- Issue date Aug 8, 2023
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of activin receptor-like kinase
- Patent number 11,634,422
- Issue date Apr 25, 2023
- Blueprint Medicines Corporation
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
MAP4K1 inhibitors
- Patent number 11,534,441
- Issue date Dec 27, 2022
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of RET
- Patent number 11,279,688
- Issue date Mar 22, 2022
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolopyridines as inhibitors of activin receptor-like...
- Patent number 11,236,086
- Issue date Feb 1, 2022
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aminopyrazoles as selective janus kinase inhibitors
- Patent number 10,875,847
- Issue date Dec 29, 2020
- Intervet Inc.
- Peter H. Fuller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aminopyrazoles as janus kinase inhibitors
- Patent number 10,766,883
- Issue date Sep 8, 2020
- Merck Sharp & Dohme Corp.
- Peter Fuller
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of RET
- Patent number 10,584,114
- Issue date Mar 10, 2020
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolotriazine inhibitors of IRAK4 activity
- Patent number 10,329,295
- Issue date Jun 25, 2019
- Merck Sharp & Dohme Corp.
- Jongwon Lim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolopyrimidine inhibitors of IRAK4 activity
- Patent number 10,329,294
- Issue date Jun 25, 2019
- Merck Sharp & Dohme Corp.
- Jongwon Lim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of activin receptor-like kinase
- Patent number 10,233,186
- Issue date Mar 19, 2019
- Blueprint Medicines Corporation
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds useful for treating disorders related to RET
- Patent number 10,227,329
- Issue date Mar 12, 2019
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of RET
- Patent number 10,183,928
- Issue date Jan 22, 2019
- Blueprint Medicines Corporation
- Joseph L. Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyridazine inhibitors of IRAK4 activity
- Patent number 10,040,798
- Issue date Aug 7, 2018
- Merck Sharp & Dohme Corp.
- Jongwon Lim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds useful for treating disorders related to RET
- Patent number 10,035,789
- Issue date Jul 31, 2018
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of RET
- Patent number 10,030,005
- Issue date Jul 24, 2018
- Blueprint Medicines Corporation
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of IRAK4 activity
- Patent number 9,969,749
- Issue date May 15, 2018
- Merck Sharp & Dohme Corp.
- Michael D. Altman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors
- Patent number 9,957,265
- Issue date May 1, 2018
- Merck Sharp & Dohme Corp.
- Christopher Dinsmore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of IRAK4 activity
- Patent number 9,943,516
- Issue date Apr 17, 2018
- Merck Sharp & Dohme Corp.
- Michael D. Altman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of IRAK4 activity
- Patent number 9,932,350
- Issue date Apr 3, 2018
- Merck Sharp & Dohme Corp.
- Michael D. Altman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of IRAK4 activity
- Patent number 9,926,330
- Issue date Mar 27, 2018
- Merck Sharp & Dohme Corp.
- Michael D. Altman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors
- Patent number 9,725,445
- Issue date Aug 8, 2017
- Merck Sharp & Dohme Corp.
- Matthew Lloyd Childers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Acyclic cyanoethylpyrazoles as janus kinase inhibitors
- Patent number 9,493,441
- Issue date Nov 15, 2016
- Merck Sharp & Dohme Corp.
- Jason Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazole carboxamides as Janus kinase inhibitors
- Patent number 9,394,282
- Issue date Jul 19, 2016
- Merck Sharp & Dohme Corp.
- Jason Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyanomethylpyrazole carboxamides as janus kinase inhibitors
- Patent number 9,328,099
- Issue date May 3, 2016
- Merck Sharp & Dohme Corp.
- Jason Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors
- Patent number 8,962,608
- Issue date Feb 24, 2015
- Merck Sharp & Dohme Corp.
- Jason Brubaker
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
INHIBITORS OF RET
- Publication number 20240417386
- Publication date Dec 19, 2024
- Rigel Pharmaceuticals, Inc.
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MAP4K1 INHIBITORS
- Publication number 20240336630
- Publication date Oct 10, 2024
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20240299387
- Publication date Sep 12, 2024
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
WILD TYPE KIT INHIBITORS
- Publication number 20240262826
- Publication date Aug 8, 2024
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MAP4K1 INHIBITORS
- Publication number 20240199648
- Publication date Jun 20, 2024
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
- Publication number 20240158398
- Publication date May 16, 2024
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MAP4K1 INHIBITORS
- Publication number 20230140954
- Publication date May 11, 2023
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MAP4K1 INHIBITORS
- Publication number 20230112729
- Publication date Apr 13, 2023
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGFR INHIBITORS
- Publication number 20230056541
- Publication date Feb 23, 2023
- BLUEPRINT MEDICINES CORPORATION
- John Emmerson Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EGFR INHIBITORS
- Publication number 20230026209
- Publication date Jan 26, 2023
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MAP4K1 INHIBITORS
- Publication number 20220323438
- Publication date Oct 13, 2022
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
- Publication number 20220315585
- Publication date Oct 6, 2022
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF RET
- Publication number 20220315560
- Publication date Oct 6, 2022
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF RET
- Publication number 20200407341
- Publication date Dec 31, 2020
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRROLOPYRIDINES AS INHIBITORS OF ACTIVIN RECEPTOR-LIKE...
- Publication number 20200331908
- Publication date Oct 22, 2020
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aminopyrazoles as Selective Janus Kinase Inhibitors
- Publication number 20200115367
- Publication date Apr 16, 2020
- Intervet Inc.
- Peter H. Fuller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMINOPYRAZOLES AS JANUS KINASE INHIBITORS
- Publication number 20190330195
- Publication date Oct 31, 2019
- MERCK SHARP & DOHME CORP.
- Peter Fuller
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF RET
- Publication number 20190185454
- Publication date Jun 20, 2019
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLOPYRIMIDINE INHIBITORS OF IRAK4 ACTIVITY
- Publication number 20180051028
- Publication date Feb 22, 2018
- MERCK SHARP & DOHME CORP.
- JONGWON LIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOTRIAZINE INHIBITORS OF IRAK4 ACTIVITY
- Publication number 20180051030
- Publication date Feb 22, 2018
- MERCK SHARP & DOHME CORP.
- JONGWON LIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRROLOPYRIDAZINE INHIBITORS OF IRAK4 ACTIVITY
- Publication number 20180051029
- Publication date Feb 22, 2018
- MERCK SHARP & DOHME CORP.
- JONGWON LIM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO RET
- Publication number 20180030032
- Publication date Feb 1, 2018
- Blueprint Medicines Corporation
- Jason D. BRUBAKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO RET
- Publication number 20180022732
- Publication date Jan 25, 2018
- BLUEPRINT MEDICINES CORPORATION
- JASON D. BRUBAKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
- Publication number 20170298069
- Publication date Oct 19, 2017
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF IRAK4 ACTIVITY
- Publication number 20170275297
- Publication date Sep 28, 2017
- MERCK SHARP & DOHME CORP.
- MICHAEL D. ALTMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF RET
- Publication number 20170267661
- Publication date Sep 21, 2017
- BLUEPRINT MEDICINES CORPORATION
- Joseph L. Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF IRAK4 ACTIVITY
- Publication number 20170247388
- Publication date Aug 31, 2017
- MERCK SHARP & DOHME CORP.
- MICHAEL D. ALTMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF IRAK4 ACTIVITY
- Publication number 20170217981
- Publication date Aug 3, 2017
- MERCK SHARP & DOHME CORP.
- MICHAEL D. ALTMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF IRAK4 ACTIVITY
- Publication number 20170209446
- Publication date Jul 27, 2017
- MERCK SHARP & DOHME CORP.
- MICHAEL D. ALTMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF RET
- Publication number 20170121312
- Publication date May 4, 2017
- BLUEPRINT MEDICINES CORPORATION
- Jason D. Brubaker
- C07 - ORGANIC CHEMISTRY

Jason D. Brubaker

Person

Patents Grantslast 30 patents

Wild type kit inhibitors

MAP4K1 inhibitors

EGFR inhibitors

MAP4K1 inhibitors

EGFR inhibitors

Inhibitors of activin receptor-like kinase

MAP4K1 inhibitors

Inhibitors of RET

Substituted pyrrolopyridines as inhibitors of activin receptor-like...

Aminopyrazoles as selective janus kinase inhibitors

Aminopyrazoles as janus kinase inhibitors

Inhibitors of RET

Pyrrolotriazine inhibitors of IRAK4 activity

Pyrazolopyrimidine inhibitors of IRAK4 activity

Inhibitors of activin receptor-like kinase

Compounds useful for treating disorders related to RET

Inhibitors of RET

Pyrrolopyridazine inhibitors of IRAK4 activity

Compounds useful for treating disorders related to RET

Inhibitors of RET

Inhibitors of IRAK4 activity

N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors

Inhibitors of IRAK4 activity

Inhibitors of IRAK4 activity

Inhibitors of IRAK4 activity

Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors

Acyclic cyanoethylpyrazoles as janus kinase inhibitors

Pyrazole carboxamides as Janus kinase inhibitors

Cyanomethylpyrazole carboxamides as janus kinase inhibitors

Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors

Patents Applicationslast 30 patents

INHIBITORS OF RET

MAP4K1 INHIBITORS

HETEROCYCLIC EGFR INHIBITORS FOR USE IN THE TREATMENT OF CANCER

WILD TYPE KIT INHIBITORS

MAP4K1 INHIBITORS

INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

MAP4K1 INHIBITORS

MAP4K1 INHIBITORS

EGFR INHIBITORS

EGFR INHIBITORS

MAP4K1 INHIBITORS

INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

INHIBITORS OF RET

INHIBITORS OF RET

SUBSTITUTED PYRROLOPYRIDINES AS INHIBITORS OF ACTIVIN RECEPTOR-LIKE...

Aminopyrazoles as Selective Janus Kinase Inhibitors

AMINOPYRAZOLES AS JANUS KINASE INHIBITORS

INHIBITORS OF RET

PYRAZOLOPYRIMIDINE INHIBITORS OF IRAK4 ACTIVITY

PYRROLOTRIAZINE INHIBITORS OF IRAK4 ACTIVITY

PYRROLOPYRIDAZINE INHIBITORS OF IRAK4 ACTIVITY

COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO RET

COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO RET

INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

INHIBITORS OF IRAK4 ACTIVITY

INHIBITORS OF RET

INHIBITORS OF IRAK4 ACTIVITY

INHIBITORS OF IRAK4 ACTIVITY

INHIBITORS OF IRAK4 ACTIVITY

INHIBITORS OF RET